NEW MATERIAL:Crystallizable monohydrate of N-(1H-tetrazol-5-yl)-phenoxy-4H- quinolizin-4-one-carboxamide sodium salt.
USE: An antiallergic drug and antitumor agent having excellent handleability because of extremely excellent water-vapor resistance and stability.
PREPARATION: N-( 1H-tetrazol-5-yl )-1-phenoxy-4H-quinolizin-4-one-3-carbax amide.sodium salt (or crystallizable tetrahydrate thereof) shown by the formula is crystallized (or subjected to crystal transition) at 40W80°C at ≥30% relative humidity or from a water-isopropyl alcohol mixed solvent to give a crystalliza ble monohydrate of the compound shown by the formula. The crystallizable tetrahydrate is obtained by crystallizing the compound shown by the formula from a water-ethanol mixed solvent.
OKAMOTO YOSHIHIKO
TADA TOSHIHARU
MOMONAGA SHINJI
Next Patent: PIPERAZINYL DERIVATIVE OF PURINE AND ISOSTER THEREOF AS HYPOGLYCEMIC AGENT